Hospital-Pharmacy Relationship Drives Generic Drug Use
Drug Topics
MAY 27, 2025
Researchers explored how relationships between physicians, pharmacists, and patients are associated with the use of generic drugs in Japanese pharmacies.
May, 2025
343 
With compounders out of the way, Lilly and Novo go after each other
PharmaVoice
MAY 5, 2025
The two obesity leaders are pulling on all levers to stay on top of the market.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Opinion: I’m a dentist from India. The fluoride debate in the U.S. horrifies me
STAT
MAY 24, 2025
Florida has just banned fluoride in public water , becoming the second state to do so. It’s part of decadeslong battle that has heated up in recent years. Local governments debate whether it belongs in the water supply. Parents question safety. Pseudoscience clouds public perception. Often, the conversation is framed as a domestic ideological battle between personal liberty and public health mandates.
PBMs launch new ad campaign to block reforms
PhRMA
MAY 5, 2025
PBM’s trade association, PCMA, recently launched a campaign to mask growing concerns over their role in the pharmaceutical supply chain and the rising cost of medicine for patients. The campaign is in response to elected officials nationwide joining the congressional momentum in calling for PBM reform. It’s time to rein in middlemen, like PBMs, who use medicines as a profit center and drive up the costs for patients, employers, and taxpayers.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Approves Teal Wand, First At-Home Self-Collection Cervical Cancer Screening Device
Pharmacy Times
MAY 9, 2025
The new at-home test aims to increase comfort and screening timeliness through a more accessible method.
Roche takes new antibiotic into phase 3 for 'urgent threat'
pharmaphorum
MAY 27, 2025
Roche is moving its antibiotic zosurabalpin into phase 3 for CRAB, potentially a big step forward in the fight against antimicrobial resistance
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
AI is already delivering pharma value — and not just in drug discovery
PharmaVoice
MAY 12, 2025
While AI-generated drugs grab headlines, the technology is making more of an impact doing less “glamorous” tasks.
STAT+: With Covid vaccine decisions, RFK Jr. unleashes an unfettered assault on public health
STAT
MAY 28, 2025
Robert F. Kennedy Jr.’s unilateral decision that the Centers for Disease Control and Prevention would no longer recommend Covid-19 boosters for healthy people during childhood or pregnancy represents a bulldozing of safeguards intended to keep public health officials honest and their decisions transparent. It also tramples on individuals’ ability to make their own decisions about medical evidence.
Eli Lilly to expand pain pipeline with $1bn SiteOne buyout
Pharmaceutical Technology
MAY 27, 2025
The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids.
FDA Grants Market Clearance to Diagnostic Blood Test for Alzheimer Disease
Pharmacy Times
MAY 19, 2025
The Lumipulse G pTau217/-Amyloid 1-42 Plasma Ratio is the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant
Pharmafile
MAY 6, 2025
Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofis consumer healthcare division, positioning Opella as a new independent leader in the global consumer health space. The deal brings Sanofi approximately 10bn in net cash proceeds. Sanofi retains a 48.2% share in Opella, with Bpifrance […] The post Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant appeared first on Pharmafile.
Suicide Risk Management Crucial in Dermatological Care
Drug Topics
MAY 18, 2025
Researchers conducted a clinical review detailing the intersection of dermatology and suicide, explaining why skin conditions lead to increased risk of poor mental health.
A startup with Theranos ties has another blood test in the works. This time, competition is waiting.
PharmaVoice
MAY 16, 2025
A stealth startup built by the partner of disgraced Theranos founder Elizabeth Holmes is taking a shot at a new blood test — an area where other companies are already making strides.
STAT+: Scientific societies call for a moratorium on using CRISPR to create genetically modified children
STAT
MAY 13, 2025
Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year international moratorium on the use of CRISPR and other DNA-editing tools to create genetically modified children, according to a draft of the declaration provided to STAT. The move — coming more than seven years after Chinese researcher He Jiankui announced the birth of the world’s first CRISPR babies — is intended to send a clear signal to the global scientific co
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Commissioner’s Magical Mystery Tour: Many Questions About this Unique Opportunity
The FDA Law Blog
MAY 27, 2025
By Dr. Naomi Lowy, Principal Drug Regulatory Expert FDA recently announced, CEO Forums: An FDA Listening Tour to Engage Pharma CEOs. These are scheduled to take place in several cities on both coasts in June and July (Link here). This tour to engage with pharmaceutical and biotech CEOs is unprecedented. According to the announcement, Commissioner Makary will be holding these along with Principal Deputy Commissioner Sara Brenner, M.D., M.P.H and Director of FDAs Center for Biologics Evaluation a
CVS Health Announces It Will Drop Zepbound and Prioritize Coverage of Wegovy
Pharmacy Times
MAY 14, 2025
The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MAY 20, 2025
With most eyes on Medicaid cuts in Congress, keep a close eye on ACA enrollment over the next six months, warn health policy experts.
Q&A: Pharmacists Bridge the Gap in Safe Medication Disposal | PQA 2025
Drug Topics
MAY 27, 2025
Mitchell Barnett, PharmD, MS, discusses what lessons can be learned from a community pharmacy drug disposal program.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
On tariffs and pricing, Big Pharma CEOs are waiting out the storm while planning for the worst
PharmaVoice
MAY 6, 2025
Chief executives at the largest drugmakers in the world are confident tariffs and pricing measures won’t be a major problem. But they’re still poised for change.
STAT+: As financial prospects for gene therapies dim, an ambitious charity picks up the torch
STAT
MAY 5, 2025
MILAN — For more than three decades, a charity here has funded research aimed at developing medicines for genetic diseases. Recently, though, it added an unusual new role — as a gene therapy company of sorts. The charity, the Telethon Foundation, took ownership from a small biotech of a drug that has been approved in Europe to treat an ultra-rare immune disorder called ADA-SCID.
Giving weight loss jabs could bolster UK economy by £4.5bn a year, study says
The Guardian - Pharmaceutical Industry
MAY 9, 2025
Providing semaglutide for all those eligible may bring productivity gains as people are able to work more Giving weight loss jabs to everyone eligible for them could boost the UK economy by 4.5bn, according to research. Worldwide, about 3.8 billion people over 25 and just under 750 million children and young people are forecast to be overweight or obese by 2050.
FDA Approves Belzutifan for Treatment of Locally Advanced, Unresectable, or Metastatic Pheochromocytoma and Paraganglioma
Pharmacy Times
MAY 14, 2025
The FDA approves belzutifan, the first oral treatment for pheochromocytoma and paraganglioma, offering a new treatment pathway for patients with these rare tumors.
7 benefits of zinc
The Checkup by Singlecare
MAY 6, 2025
Zinc is an essential nutrient for many bodily processes, such as immune function and wound healing. Your body doesnt naturally produce it, so you must consume it in the foods you eat or take a supplement to avoid a zinc deficiency. Luckily, many foods you probably already eat are chock-full of zinc, including seafood, red meat, poultry, whole grains, and legumes.
Development of AI is Essential to Pharmacy Education
Drug Topics
MAY 28, 2025
Researchers conducted a scoping review to evaluate conversational AI agents and their use in pharmacy education.
With the third round of Medicare price negotiations on the way, here’s how the policy is shifting
PharmaVoice
MAY 19, 2025
HHS issued guidance for the third cycle, teeing up another 15 drugs to be selected by early next year.
Mental health care may be harder to obtain after HHS rule reversal
STAT
MAY 13, 2025
For a recent therapy session, Andria Donaghy’s insurance plan paid her psychiatric nurse practitioner only $11 on a $125 service. “To even put that on paper is insulting,” she said. “These people give their lives [to help others] and that’s what you pay them?
FDA accepts Novo Nordisk’s NDA submission for weight management therapy
Pharmaceutical Technology
MAY 5, 2025
The US FDA has accepted Novo Nordisks new drug application (NDA) submission for the 25 mg oral formulation of Wegovy (semaglutide).
Carefully Consider Optimal Timing of RSV Vaccination in Older Adults
Pharmacy Times
MAY 13, 2025
Administration during peak vaccine effectiveness provides maximal protective benefit
Key trends and technologies in drug delivery for 2025 and beyond
European Pharmaceutical Review
MAY 5, 2025
Drug delivery technology is undergoing rapid innovation worldwide. Pharmaceutical manufacturers are adopting advanced delivery platforms to improve drug efficacy and patient compliance, while scaling production for global distribution. In fact, industry analysis shows drug delivery innovation is at an all-time high globally. From nanotechnology-based carriers to smart inhalation devices, these developments are reshaping how therapies are manufactured and administered.
Tirzepatide Shows Superior Weight Loss Over Semaglutide in Phase 3 Trial
Drug Topics
MAY 12, 2025
Tirzepatide (Zepbound) demonstrated superiority compared to semaglutide (Wegovy) across the primary end point and 5 key secondary end points.
Is pharma ready to let go of animal testing?
PharmaVoice
MAY 2, 2025
Regulators have signaled their willingness to embrace alternative tests and guide the industry in new directions.
Opinion: How to stop the shift of drug discovery from the U.S. to China
STAT
MAY 6, 2025
Five years ago, U.S. pharmaceutical companies didn’t license any new drugs from China. By 2024, one-third of their new compounds were coming from Chinese biotechnology firms. Why are U.S. drugmakers sending their business to China? As in many other industries, it’s so much cheaper to synthesize new compounds inside Chinese biotechnology firms once a novel biological target has been discovered in American laboratories.
FDA awards cancer drug approvals to AbbVie and MSD
Pharmaceutical Technology
MAY 15, 2025
The FDA has approved MSDs Welireg for rare adrenal tumours, and AbbVies Emrelis for treating c-Met+ lung cancer patients.
Let's personalize your content